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BYPASS CONDUIT VESSEL 
WALL BIOLOGY 
SUBSTANTIALLY 
INFLUENCES DOWNSTREAM 
MYOCARDIAL CONTRACTILE 
RESPONSE TO IN JURY 
FROM ISCHEMIA AND 
REPERFUSION 
Coronary vascular intraluminal release of endogenous endothelium-de- 
rived substances, such as prostacyclin, may affect downstream cardiac 
myocyte ontractile function. With a "chronic" canine model of endotheli- 
alized and deendothelialized internal thoracic artery coronary grafts, we 
tested the hypothesis that higher basal release of endothelium-derived 
prostacyclin in internal thoracic artery bypass conduit efltuent aceelerates 
fnnctional recovery of postischemic stunned myocardium in the intaet 
circulation. Eleven dogs underwent left internal thoraeic artery-left cir- 
cumflex artery bypass, and the proximal circumflex artery was then ligated. 
Internal thoracic artery eonduit endothelium was denuded by balloon 
catheter in five dogs before grafting and left intact in six dogs. After 7 days, 
awake dogs were studied to measure myocardial segment length in the 
circumflex region with ultrasonic dimension transducers, left ventricular 
pressure with micromanometers, and circnmflex artery flow with an 
ultrasonic flow probe. Regional contraetile funetion was quantified by the 
area beneath the l inear preload recruitable stroke work relationship at 
baseline and at intervals after a 15-minute circumflex graft occlusion 
followed by 3 hours of reperfusion. Heart rate, left ventricnlar peak 
pressure, left ventricular end-diastolie pressure, left ventricular peak first 
derivative of pressure (dP/dt), and cireumfiex ttow were similar (all p not 
significant) in endothelialized and nonendothelialized dogs during isch- 
emia and reperfusion. Ischemia reduced the preload recruitable stroke 
work relationship to 44% - 35% of control values (p < 0.01) in endothe- 
lialized dogs and to 47% - 18% of control values in nonendothelialized 
dogs (t7 < 0.01) at 15 minntes of reperfusion, indicating a similar (p not 
significant) initial degree of injury. Dnring 3 honrs of reperfusion, the 
preload recruitable stroke work relationship returned to 51% - 17% of 
control values in endothelialized dogs but to only 35% - 20% of eontrol 
values in nonendothelialized dogs (p < 0.02). Basal intraluminal release of 
endogenous prostanoids in excised internal thoracic artery conduits was 
subsequently quantified by ex vivo bioassay of vasoactive properties of 
eonduit etHuent on normal coronary artery smooth mnscle. Endothelialized 
condnits induced greater smooth muscle relaxation than did nonendothe- 
lialized condnits (67% vs 23%), and this increased relaxation by endothe- 
lialized conduits was eliminated by indomethaein, a blocker of prostanoid 
synthesis. These data indicate that coronary bypass eonduit endothel ium- 
derived substanees, such as prostacyclin, signifieantly influence down- 
stream myocardial eontraetile response to ischemia and reperfusion, 
independent of alterations in coronary flow in the intact circulation. 
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S uperior performance of the internal thoracic artery (ITA) for coronary artery bypass grafting 
is the result of intrinsic biologic properties of the 
ITA conduit. In addition to anatomic and geometric 
advantages, which result in a more favorable flow 
velocity profile, lower shear stresses, 1-3 and greater 
resistance to smooth muscle intimal hyperplasia nd 
atherosclerotic changes, 4' 5 there are also important 
differences in production of the endothelium-de- 
rived polypeptide prostacyclin by ITA and saphe- 
nous vein grafts. Endogenous endothelial release of 
prostacyclin, a coronary vasodilator and an inhibitor 
of platelet aggregation and platelet-induced vaso- 
constriction, is significantly greater in human ITA 
than in saphenous vein. 6-9 These and perhaps other 
characteristics of conduit vessel wall biology proba- 
bly also c0ntribute to improved performance of the 
ITA conduit in the coronary circulation. 
Previously, substantial attention has been directed 
toward characterization f how intraluminal release 
of endothelium-derived prostacyclin may affect the 
local coronary vascular environment o promote 
vasodilation and retard atherosclerotic degenera- 
tion. 1° Increasing evidence now indicates that coro- 
nary vascular intraluminal release of endothelium- 
derived substances may also exert significant 
endocrine effects on downstream cardiac myocyte 
contractile function and may act to influence myo- 
cellular t01erance to ischemic and reperfusion in- 
jury. 11-17 Stimulation of endothelium-derived nitric 
oxide has been demonstrated to have detrimental 
effects on contractile performance of dysfunctional 
myocytes] 3-17 Conversely, stimulation of endoge- 
nous prostacyclin synthesis 11' 12, 18 and administra- 
tion of exogenous prostacyclin 19-21 or prostacyclin 
analog22-24 have been shown to have beneficial 
cardioprotective effects against myocardial ischemia 
and reperfusion injury and to attenuate postisch- 
emic myocardial stunning. In addition to its actions 
as a vasodilator and platelet suppressant, prostacy- 
clin is known to oppose the effects of leukocyte 
adhesion moleculesY to inhibit the transmigration 
of neutrophils into reperfused myocardium, and to 
inhibit the neutrophil oxidative burst. 21'23, 24 The 
attenuation of neutrophil-mediated free-radical in- 
jury during reperfusion is thought o be a potential 
mechanism by which prostacyclin may enhance post- 
ischemic myocardial functional recovery. Endoge- 
nous ITA conduit endothelium- derived factors such 
as prostacyclin could be released in sufficient con- 
centration~ in vivo to exert significant biologic ef- 
fects and influence downstream myocellular con- 
tractile function in the intact circulation, but this has 
not previously been well defined. 
We therefore undertook a study that used endo- 
thelialized and deendothelialized ITA conduits 
grafted to a proximally ligated coronary artery in the 
"chronic" canine model to develop a suitable exper- 
imental model for the investigation of bypass con- 
duit endothelium-mediated myocardial events in 
the intact circulation. We tested the hypothesis that 
higher basal release of endothelium-derived prosta- 
cyclin in ITA bypass conduit effluent may have 
important effects on downstream yocetlular con- 
tractile function and act to accelerate functional 
recovery of postischemic stunned myocardium. 
Methods 
Experimental protocol 
ITA grafting and instrurnentation. Eleven adult mongrel 
dogs (27 -- 3 kg) were anesthetized with pentobarbital (30 
mg/kg administered intravenously), intubated, and me- 
chanically ventilated with oxygen. Under sterile condi- 
tions, a left thoracotomy was performed through the 
fourth intercostal space and the left ITA pedMe was 
dissected from the chest wall from its origin at the left 
subclavian artery to the fifth intercostal space. Heparin 
(100 U/kg) was administered intravenously and the distal 
ITA was ligated and divided so that the in situ ITA graft 
length was approximately 12 cm. The pericardium was 
opened and the proximal portion of the left circumflex 
coronary artery (LCX), beginning at its origin at the left 
main coronary artery, was exposed for a length of approx- 
imately 1.5 cm in the atrioventricular g oove beneath the 
left atrial appendage. Dogs then underwent coronary 
artery bypass grafting with the distal end of the in situ ITA 
graft anastomosed to the proximal LCX. To avoid extra- 
corporeal bypass, a temporary intraluminal coronary 
shunt was used to maintain LCX myocardial blood flow 
during anastomosis of the ITA to the coronary artery in 
the beating heart, as described in detail elsewhere. 26In 
brief, the proximal end of a silicone elastomer catheter 
(0.062-inch i.d. Silastic catheter; Dow Corning Corp., 
Medical Materials, Midland, Mich.) was inserted through 
a small arteriotomy into the right ITA, and pulsatile btood 
flow through the shunt was visually confirmed. Lidocaine 
(1 mg/kg) was administered intravenously, and the proxi- 
mal LCX was ligated immediately beyond its origin from 
the left main coronary artery. An oblique arteriotomy was 
made in the LCX wall, with a distal suture loop around 
the LCX placed under tension to avoid back bleeding. The 
distal end of the silicone elastomer shunt was passed 
through the LCX arteriotomy to just beyond the looped 
suture but proximal to the origin of the first obtuse 
marginal branch of the LCX. Ties were secured and a 
third silk suture was then positioned proximal to the tip of 
the shunt to prevent back bleeding when the LCX was 
opened. The shunt was unclamped and blood flow was 
reestablished into the distal LCX. Reestablishment of 
blood flow to the LCX region was visually confirmed by 
immediate resolution of myocardial cyanosis and resump- 
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tion of regional myocardial systolic ontraction. On aver- 
age, coronary artery occlusion lasted less than 60 seconds. 
A longitudinal arteriotomy was then made in the LCX 
over the shunt, and the distal end of the IMA was 
anastomosed to the LCX in a bloodless field with running 
7-0 polypropylene sutures. After completion of the anas- 
tomosis, the shunt was removed and the LCX was ligated 
just proximal to the anastomosis. Blood flow into the 
distal LCX was then completely dependent on the ITA 
graft. 
In six of 11 dogs, the ITA was not probed or instru- 
mented in any way before anastomosis and the ITA 
endothelium was left intact and undisturbed. These dogs 
were designated the endothelialized (ENDO) group. In 
the other five of 11 dogs, designated the nonendothelial- 
ized (NoENDO) group, before anastomosis of the ITA 
graft the ITA endothelium was denuded by insertion of a 
balloon catheter (5F) into the ITA followed by gentle 
balloon inflation and withdrawal of the catheter over the 
entire length of the ITA graft. ITA endothelial denuda- 
tion by this method, described elsewhere in detail, 27-29 was 
subsequently confirmed in representative dogs by scan- 
ning electron microscopic examination of the luminal 
surface of excised ITA grafts at the completion of the 
study. The presence of an intact endothelium was also 
confirmed in representative dogs in the ENDO group by 
scanning electron microscopy. Dogs were allocated to 
ENDO and NoENDO groups in a random manner. 
In all dogs, pneumatic cuff occluders were placed 
around the superior and inferior venae cavae and around 
the distal ITA graft just proximal to the LCX anastomosis. 
An ultrasonic flow probe (inner diameter 2 mm; Tran- 
sonic Systems, Inc., Ithaca, N.Y.) was placed around the 
LCX just distal to the anastomosis to measure LCX 
coronary blood flow. A bipolar pacing electrode was 
sutured to the surface of the left atrium. A silicone rubber 
tube (inner diameter 2.6 mm, outer diameter 4.9 mm; 
Dow Corning) was implanted in the base of the left atrial 
appendage for later passage of a micromanometer into 
the left ventricle. A similar tube with multiple side holes 
was positioned in the pleural space adjacent o the left 
ventricle for measurement of pleural pressure. Pairs of 
miniature subepicardial pulse-transit ultrasonic dimension 
transducers (outer diameter 1.5 mm; Physiological Mon- 
itoring Systems Group, Durham, N.C.) were implanted 
into the left ventricle to measure myocardial segment 
dimension. One pair was positioned in the distribution of 
the LCX distal to the ITA graft anastomosis and a second 
pair was positioned in the distribution of the left anterior 
descending coronary artery. Each pair was aligned 10 to 
15 mm apart along the minor axis circumference of the 
left ventricle midway between apex and base. Cables and 
tubes were passed through the chest wall into a dorsal 
subcutaneous pouch, the pericardium was left opened, 
and the thoracotomy was closed in layers. Each dog was 
allowed to recover for 7 days, receiving intramuscular 
injections of butorphanol tartrate (0.5 mg) for pain and 
penicillin G (Bicillin) (1.25 MU) and ora! doses of aspirin 
(81 mg daily). 
Data acquisition. After 7 days, dogs were studied in the 
conscious tate lying quietly on their right side. Intramus- 
cular morphine (0.7 mg/kg) was given and cable connec- 
tors were exteriorized through a small skin incision with 
1% lidocaine local anesthesia. Ultrasonic dimension 
transducers were connected to a sonomicrometer (Davis 
Associates, Durham, N.C.). Micromanometers were passed 
through the implanted silicone rubber tubes into the left 
ventricle and into the pleural space adjacent o the left 
ventricle. The left atrium was paced at a constant rate. 
Lidocaine (1 mg/kg) was administered, and 10 minutes 
later pressure, dimension, and coronary flow data were 
recorded. The ITA graft to the LCX was then occluded 
for 15 minutes and reperfused. Lack of flow during LCX 
graft occlusion and restoration of flow after occluder 
release were confirmed by flow probe measurement. At
the end of the 15-minute LCX occlusion, the occluder was 
gradually released, initially allowing LCX flow to return 
only to control preischemic values to attenuate the reper- 
fusion hyperemic response and to control for any poten- 
tial differences between ENDO and NoENDO groups in 
LCX reperfusion flow. 
Data were acquired at control before ischemia, just 
before coronary reperfusion, and at 15, 30, 60, 90, 120, 
150, and 180 minutes after reperfusion. At each time 
point, static data were recorded at a constant heart rate 
and data were also recorded over a range of left ventric- 
ular end-diastolic volumes produced by transient (5- to 
10-second) occlusion of the venae cavae for 10 to 25 
cardiac ycles. At the conclusion of 3 hours of reperfusion, 
dogs were killed by deep barbiturate anesthesia and the 
hearts and ITA grafts were excised. 
In five dogs (three ENDO, two NoENDO) basal in- 
traluminal release of endogenous prostanoid synthesis by 
ITA conduits was quantified by ex vivo bioassay of the 
vasoactive properties of ITA conduit elttuent, as described 
elsewhere in detail. 3° In brief, excised ITA grafts were 
immediately immersed in cool, oxygenated physiologic 
salt solution of the following composition (in millimoles 
per liter): sodium chloride, 118.3; potassium chloride, 4.7; 
magnesium sulfate, 1.2; potassium phosphate, 1.22; CaC12, 
2.5; sodium hydrogen carbonate, 25.0; and glucose, 11.1. 
The ITA was gently cleaned of surrounding tissue and 
care was taken not to touch the luminal surface. ITA 
conduits were mounted on a stainless teel cannula and 
perfused with oxygenated physiologic solution at 37 ° C at 
a constant flow rate (5 ml/min). Beneath the ITA con- 
duits, isolated 3 mm rings of coronary artery smooth 
muscle from which the endothelium had been mechani- 
cally removed (obtained from a control dog not otherwise 
0perated on) were suspended in a 25 ml organ chamber 
filled with oxygenated physiologic solution at 37 ° C. Rings 
were suspended by two stainless teel clips anchored and 
connected to a strain gauge (Statham Gould UC2; Spec- 
tramed Inc., Critical Care Division, Oxnard, Calif.) for 
measurement of isometric force. The coronary vessel rings 
were first superfused for 60 minutes with control solution 
and stretched in stepwise fashion to optimal tension 
(10 g). Relaxation of bioassay rings in response to direct 
perfusion with ITA conduit effluent was examined uring 
bioassay ring contraction caused by prostaglandin F2~. 
The absence of endothelium on bioassay rings was con- 
firmed by the lack of relaxation to calcium ionophore 
A23187 (10 .6 mol/L). Relaxation of bioassay rings was 
also measured after stimulated release of ITA conduit 
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vasoactive substances elicited by 200 txl of calcium iono- 
phore A23187 (10 6 mol/L) injected into the perfusate 
above the ITA conduit, both with and without addition of 
indomethacin (10 » mol/L), a blocker of endogenous 
prostanoid synthesis, to the ITA perfusate. The degree of 
ring relaxation is indicative of the quantity of intraluminal 
release of endogenous vasoactive substance produced by 
the ITA conduit. Relaxation is expressed as a percentage 
of the maximal contraction achieved by prostaglandin F2~. 
ITA graft s from dogs in the ENDO and NoENDO groups 
that were not bioassayed for endogenous prostanoid 
synthesis were processed for scanning electronmicro- 
graphic examination of the ITA luminal surface. 
All animals received humane care in compliance with 
the "Principles of Laboratory Animal Care" formulated 
by the National Society for Medical Research and the 
"Guide for the Care and Use of Laboratory Animals" 
published by the National Institutes of Health (NIH 
publication o. 85-23, revised 1985). The procedures and 
handling of animals were reviewed and approved by the 
Institutional Animal Care and Use Committee of the 
Mayo Foundation. 
Data analysis. Pressure, dimension, and flow data were 
filtered with a 50 Hz low-pass analog filter and digitized 
at an 8-channel sweep speed of 200 Hz by an analog-to- 
digital converter (model 5025MF; ADAC, Woburn, 
Mass.). The analog-to-digital conversion time per channel 
was 30 msec, creating a phase delay between channels of 
less than 45 degrees. After data were collected and stored 
on a hard disk by personnel computer (Reason Technol- 
ogy Inc., Minneapolis, Minn.), data analysis was accom- 
plished on a microcomputer (DEC Vaxstation 3100; Dig- 
ital Electronic Corporation, Maynard, Mass.) by means of 
commercial interactive software (Davis Associates) and 
software developed in our laboratory. Instantaneous left 
ventricular transmural pressure was calculated as the 
difference between left ventricular pressure and pleural 
pressure. The first derivative of left ventricular transmural 
pressure (dP/dt) was determined from a running 5-point 
polyorthog0nal transformation f the digitized ventricular 
pressure waveform. Cardiac cycles were automatically 
defined with dP/dt criteria. Regional eft ventricular sys- 
tolic contractile function was quantified by the linear and 
load-independent preload recruitable stroke work (SW) 
relationship, an analysis of ventricular myocardial seg- 
ment ability 1:o generate as a function of end-diastolic 
length (EDL). This analysis is a highly sensitive, useful 
parameter to assess regional myocardial dysfunctio n after 
acute ischemic injury, as described elsewhere in de- 
tail.31,32 In brief, regional left ventricular SW values were 
calculated from instantaneous transmural pressure (P) 
and dimension (L) data for each cardiac cycle as follows: 
( 
SW JP .  dL (1) 
Data from each vena caval occlusion were fitted to the 
following equation: 
SW = Mw (EDL l--~v) (2) 
relating SW to EDL where Mw is the slope and Lw is the 
x-axis intercept. Preload recruitable work area (PRWA) 
was defined as the area under the SW versus EDL 
regression line and was calculated as follows: 
PRWA = Nw/2 × (Lwmax - Lw) 2 (3) 
where L . . . .  was the maximal x-intercept value obtained 
for a given myocardial segment over the entire experi- 
ment. Changes in ventricular contractile function were 
reftected as changes in Mw and L,v and by changes in 
PRWA, which reflected changes in both slope, M w, and 
x-intercept, L w (Fig. 1). For each dog, M w, L w, and PRWA 
were determined from equations 2 and 3 for both the 
LCX and left anterior descending corónary artery regions 
for each vena caval occlusion. Mean values were calcu- 
lated for three to five vena caval occlusions performed at 
baseline before ischemia produced by LCX occlusion and 
after ischemia t 15, 30, 60, 90, 120, 150, and 180 minutes 
of reperfusion. Standard hemodynamic data (heart rate, 
left ventricular peak pressure, left ventricular end-dia- 
stolic pressure, left ventricular peak dP/dt, and LCX flow) 
were also acquired. 
All data are presented as mean _+ standard eviation 
except as otherwise noted. Statistical analyses were per- 
formed with paired and unpaired t-tests and orte- and 
two-way analyses of variance with the Newman-Keuls test 
to localize differences as appropriate. Statistical signifi- 
cance was accepted at p < 0.05. 
Results 
Scanning electron microscopy of ITA grafts. 
Scanning electron microscopic views of the luminal 
surfa¢e of an ITA  graft from representative dogs in 
the ENDO and NoENDO groups are shown in Fig. 
2. In grafts from the ENDO group (Fig. 2, A) the 
ITA endothel ium is intact and endothelial cell bor- 
ders are weil demarcated, with elevated central 
portions of the cells indicative of the presence of 
nuclei, and there is minimal widening of intracellu- 
lar borders. In the grafts from the NoENDO group 
(Fig. 2, B) the ITA  intimal surface is denuded of 
endothelial cells, with exposure of the subendothe- 
lial matrix, confirming ITA  deendothelialization ac- 
complished by balloon catheter. 
Circumflex eoronary artery blood flow. At base- 
line before LCX graft occlusion, mean LCX coro- 
nary blood flow was 60 + 4 ml/min in the ENDO 
group and 61 _+ 21 tal/min in the NoENDO group (p 
not significant). After release of the LCX graft 
occlusion, early reperfusion flows were similar (p 
not significant) in the ENDO and NoENDO groups 
and did not differ (p not significant) from control 
preischemic values in either group. LCX cor0nary 
blood flows did not differ (all p not significant) at 
any time during reperfusion in the ENDO and 
NoENDO groups (Fig. 3). 
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Fig. I. A, Characteristic plot of instantaneous left ventricular t ansmural pressure (LVP) and myocardial 
segment dimension in the region of the circumflex artery for cardiac ycles over a range of end-diastolic 
volumes produced by transient vena caval occlusion. B, Expressing left ventricular regional SW as a 
function of EDL for each cardiac cycle (equations 1 and 2 in text) yields a highly linear relationship 
precisely quantifiable by a slope, Mw, and an x-axis intercept, Lw. C, Computation ofPRWA as area under 
segmental SW versus EDL relationship (equation 3 in text) for two different SW versus EDL relationships 
in the same dog at different times. Lwl and Lw2 are relationship x-axis intercepts for individual study times 
and Lwmax is the maximal value of Lw for the entire experiment. 
Hemodynamics during regional ischemia and 
reperfusion. As summarized in Fig. 4, the effects of 
LCX graft occlusion and reperfusion on heart rate, 
left ventricular peak pressure, left ventricular end- 
diastolic pressure, and left ventricular peak dP/dt 
were similar (all p not significant) in the ENDO and 
NoENDO groups, indicating no differences in 
global hemodynamics between the two groups. 
Regional myoeardial eontraetile funetion. At 
baseline before LCX graft occlusion, myocardial 
contractile function in the LCX region did not differ 
in the ENDO and NoENDO groups. The slope, M w, 
and x-intercept, Lw, of the LCX regional preload 
recruitable SW relationship, and PRWA were sim- 
ilar (all p not significant) in ENDO and NoENDO 
groups (Table I). 
In both the ENDO and NoENDO groups 15 
minutes of LCX graft occlnsion resulted in signifi- 
cant depression of myocardial contractile function 
in the LCX region, reflected as a significant reduc- 
tion in regional PRWA (Table I). LCX graft occlu- 
sion reduced LCX regional PRWA to 44% _+ 35% 
of the preischemic control value in the ENDO group 
and to 47% _+ 18% of the preischemic control value 
in the NoENDO group (both p < 0.01) at 15 
minutes of reperfusion. The decrease in PRWA 
measured in the LCX region after ischemia at 15 
minutes of reperfusion was similar (p not signifi- 
cant) in the ENDO and NoENDO groups, indicat- 
ing a similar initial degree of ischemic injury mea- 
sured during early reperfusion in the two groups of 
dogs (Table I). 
During subsequent reperfusion, however, there 
was an accelerated recovery of LCX regional con- 
tractile function in the ENDO group compared with 
that seen in the NoENDO group (p < 0.02; (Fig. 5). 
By 3 hours of reperfusion, LCX regional PRWA 
returned to 51% ± 17% of preischemia control 
values in the ENDO group but remained epressed 
at only 35% ± 20% of preischemia control values in 
the NoENDO group. 
Myocardial contractile function in the distribution 
of the left anterior descending coronary artery, as 
assessed by M w, L w, and PRWA of the regional 
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Fig. 2. A, From a representative dog in the ENDO group, the intraluminal surface of a noninstrumented 
ITA graft 7 days after anastomosis to the circumflex coronary artery. The endothelium is intact, with well 
demarcated endothelial cell borders, elevated central portions of the cells indicative of the presence of 
nuclei, and minimal widening of intracellular spaces (Scanning electron micrograph; original magnification 
× 1600). B, From a representative dog in the NoENDO group, the intraluminal surface of an ITA graft 7 
days after balloon catheter deendothelialization and anastomosis to the circumflex coronary artery. The 
intimal surface is denuded of endothelial cells and the subendothelial matrix is exposed (scanning electron 
m!crograph; original magnification × 1600). 
preload recruitable SW relationship, did not differ 
(all p not significant) in the ENDO and NoENDO 
groups at baseline before LCX graft occlusion. LCX 
graft occ!usion resulted in no significant depression 
of contractile function in the region of the left 
anterior descending coronary artery; Mw, Lw, and 
PRWA remained similar (all p not significant) to 
control preischemic values in both the ENDO and 
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Fig. 3. Effects of circumflex graft occlusion and reperfusion on circumflex coronary flow in ENDO and 
NoENDO groups. Values are mean -+ standard error of the mean. All valuesp not significant (ns) versus 
control preischemia v lue by one-way analysis of variance for repeated measures for both ENDO and 
NoENDO groups. Difference between ENDO and NoENDO groups tested by two-way analysis of variance 
for repeated measures. 
NoENDO groups. There were also no differences (p
not significant) between the ENDO and NoENDO 
groups in contractile function in the control left 
anterior descending region at any time during LCX 
reperfusion. 
Bioassay of ITA graft etfluent. Ex vivo bioassay of 
excised ITA conduit effluent demonstrated that 
elfluent from dogs in the ENDO group induced 
substantially greater elaxation of coronary artery 
smooth muscle rings than did eonduit elfluent from 
dogs in the NoENDO group (Fig. 6). The increased 
smooth muscle relaxation induced by conduit efftu- 
ent from dogs in the ENDO group was substantially 
reduced by addition to conduit perfusate of indo- 
methacin, a blocker of endogenous prostanoid syn- 
thesis. This indicates greater intraluminal release of 
prostacyclin or of a vasoactive prostanoid similar to 
prostaeyclin the endothelialized conduit. 
Discussion 
These data in the conscious canine model of 
regional myocardial isehemia nd reperfusion dem- 
onstrate that bypass conduit vessel wall biology 
significantly influences downstream yocardial con- 
tractile response to ischemia nd reperfusion. Myo- 
cardial regions perfused by endothelium-containing 
ITA conduits demonstrate accelerated recovery of 
contractile function after being subjected to a 15- 
minute period of coronary artery occlusion and 3 
hours of reperfusion. This difference in myocardial 
functional recovery was not related to differences 
in total regional coronary blood flow during reper- 
fusion or to differences in global hemodynamics 
during ischemia and reperfusion. The enhanced 
functional recovery of myocardial regions perfused 
by endothelium-containing conduits was associated 
with elevated levels of prostacyclin ora prostacyclin- 
like substance in bypass conduit effluent. 
In this study, we used balloon catheter endothelial 
denudation of ITA conduits in a chronic canine 
model of coronary bypass to the circumflex artery 
with proximal ligation of the native coronary vessel 
to characterize downstream effects of endothelium- 
derived factors, in particular prostacyclin, on myo- 
cellular function in the intact circulation. Our intent 
was to analyze the contractile response to ischemia 
and subsequent reperfusion in myocardial regions 
perfused by conduits with disparately high and low 
levels of basal endogenous intraluminal release of 
endothelium-derived prostacyclin. Previous work 
has demonstrated the high capacity for endogenous 
prostacyclin synthesis by canine 28' 33 and human ITA 
endothelium 6,7 Probing of the canine ITA to dis- 
rupt endothelial integrity has been shown to result 
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Fig. 4. Effects of circumflex graft occlusion and reperfusion on heart rate, left ventricular (LV) peak 
pressure, left ventricular end-diastolic pressure, and left ventricular peak dP/dt in ENDO and NoENDO 
groups. Values are mean _+ standard error of the mean. All values p not significant (ns) versus control 
preischemia value by one-way analysis of variance for repeated measures for both ENDO and NoENDO 
groups. Differences between ENDO and NoENDO groups tested by two-way analysis of variance for 
repeated measures. 
Table I. Effects of cimurnflex grafi occlusion and reperfusion on myocardial contractile function in the 
circumflex region quantified by slope, M~, x-intercept, Lw, and PRWA in ENDO and NoENDO groups 
RepeCusion 
Preischemia 15 min 30 min 60 min 90 min 120 min 150 min 180 min p* 
M w (erg .  cm 3.103)  
ENDO 125 _+ 34 126 + 55 142 _+ 38 140 -- 36 133 _+ 48 
NoENDO 154 + 80 123 ± 66 142 _+ 84 127 _+ 59 109 ± 42 
L w (mm) 
ENDO 10.7_+ 1.0 11.6 ± 1.4 11.6_+ 1.3 11.4 + 1.2 11.3 _+ 1.2 
NoENDO 14.6 _+ 5.9 15.2 + 5.7 15.2 _+ 5.8 15.5 ± 5.9 15.5 ± 5.8 
PRWA (%)t  
ENDO 100 44 + 35 44 _+ 28 52 ± 26 55 ± 21 
NoENDO 100 47 + 18 58 -- 33 39 _+ 25 36 ± 26 
! 
128 ± 35 113 _+ 21 119 + 48 
113 _+ 62 95 ± 36 91 _+ 48 
11.3 _+ 1.3 11.1 _+ 1.2 11.3 + 1.4 
15 .5±5.8  15.3_+5.8 15.2_+5.9 
57 ± 18 63 + 25 51 _+ 17 
34_+19 40±31 35_+20 
NS 
NS 
<0.02 
÷ Values mean _ standard eviation. NS, Not significant. 
*Differences be~een ENDO and NoENDO groups tested by two-way analysis of variance for repeated measures. 
tPRWA expres~ed as percentage of preischemia value. 
in a significant reduction in prostacyclin release in 
ITA effluent. 28 Deendothelialization by the balloon 
catheter m¢thod results in selective ndothelial den- 
udation without disruption of the undertying inter- 
nal elastic iamina or significant injury to the media 
and does not result in chronic myointimal hypercel- 
lularity.27,2~,34 Also, balloon catheter endothelial 
denudation has been shown to result in minimal 
platelet deposition on the luminal surface of canine 
vessels in the coronary circulation and has been 
shown not to affect resting coronary blood flow or 
the hyperemic flow response after transient coro- 
nary occlusion. 34 In this study, examinations of ITA 
conduit luminal surfaces by scanning electron mi- 
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NoENDO groups tested by two-way analysis of variance for repeated measures. 
croscopy confirmed selective endothelial denuda- 
tion by the balloon catheter technique. In addition, 
ex vivo bioassay data confirmed isparately high and 
low concentrations of prostacyclin, or of a prostan- 
oid with vasodilator activity similar to prostacyclin, 
in effluent of endothelialized and deendothelialized 
ITA conduits, respectively. Nonetheless, we were 
unable to detect differences in total coronary blood 
flow at baseline. Because of the study design, reper- 
fusion flows in myocardial regions perfused by the 
two types of conduits also did not differ. We chose to 
use an ischemic period limited to 15 minutes, a 
duration of ischemia known to cause no myocardial 
necrosis but to result in prolonged systolic contrac- 
tile dysfunction that persists for as long as 24 hours 
of reperfusion. 32Precise quantification of the re- 
gional contractile dysfunction and recovery in this 
model utilizing the load-independent preload re- 
cruitable SW relationship has been described else- 
where .  31-32 
This study demonstrated an association between 
improved functional recovery of postischemic smnned 
myocardium and regional myocardial perfusion 
through an endothelium-containing conduit. A clear 
causal relationship between increased release of 
endothelium-derived prostacyclin i  bypass conduit 
etfluent and accelerated myocardial recovery was 
not established in this study. Other work, however, 
has more directly demonstrated a myocardial pro- 
tective function of prostacyclin. Prostacyclin and a 
chemically stable analog of prostacyclin, iloprost, 
have previously been shown to be protective in a 
number of animal models of myocardial ischemia 
and reperfusion. 11'12' 19-23 The administration of 
exogenous prostacyclin analog has been demon- 
strated to accelerate functional recovery of revers- 
ibly damaged, stunned myocardium after transient 
regional ischemia in the intact canine in a dose- 
dependent, ime-dependent manner, a4 Administra- 
tion of iloprost immediately before reperfusion results 
in significant improvement in regional functional 
recovery, suggesting that beneficial effects of ilo- 
prost occur during reperfusion. Functional recovery 
is greater when administration is begun before 
ischemia, however, indicating beneficial actions of 
iloprost both before and during coronary occlu- 
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100 sion. 24 The enhancement of postischemic functional 
recovery of stunned myocardium by prostacyclin 
analog has been shown not to be mediated either by 
alterations in transmural myocardial blood ftow 
distribution or by preservation of myocardial ade- 
nine nucleotide content. Rather, the mechanism by 
which iloprost accelerates recovery of stunned myo- 
cardium seems to be mediated by inhibition of 
neutrophil-derived free radicals21, 23, 24 during 
reperfusion. Although they do not exert a direct 
superoxid e scavenging action, prostacyclin and pros- 
tacyclin analogs do inhibit endothelial adhesion of 
neutrophi!s, retard neutrophil transmigration i to 
reperfused myocardium, and block the oxidative 
burst of stimulated neutrophils. 21' 23, 25 
Other studies have demonstrated that redirection 
of endogenous prostanoid synthesis by inhibitors of 
thromboxane synthetase 12'3», 36 to enhance prosta- 
cyclin production is also associated with improve- 
ment in myocardial functional recovery, reduction in 
infarct size, and suppression of reperfusion dys- 
rhythmias, These studies have demonstrated de- 
creased endogenous thromboxane rel ase and in- 
creased release of 6-keto-PGFl~, a stable metabolite 
of prostacyclin, in coronary venous eNuent from 
postischemic myocardial regions and have shown 
that the beneficial effects of redirected prostanoid 
synthesis are abolished by the addition of indo- 
methacin but are unaffected by thromboxane r cep- 
tor blockade. 12 This confirms that accelerated myo- 
cardial recovery is not caused by reduction of 
endogenous thromboxane production but rather is 
attributable to increased endogenous prostacyclin 
synthesis. In addition to playing a role as a cytopro- 
tective and vasodilator agent, prostacyclin also has 
fibrinolytic and antithrombotic activity, which may 
also affect transmural microvascular coronary ftow 
distribution and favorably influence postischemic 
myocardial performance. The exact mechanism and 
role of endothelium-derived prostacyclin i  mediat- 
ing myoceilular performance and tolerance to isch- 
emia and lreperfusion injury remain to be deter- 
mined. 
There are several implications of this study re- 
garding tl~e use of bypass conduits in the coronary 
circulation in clinical practice. First, he potential 
benefits associated with use of an arterial conduit 
are further emphasized. In addition to the known 
superior l~ng-term patency rates of ITA grafts, our 
findings suggest hat there may be additional bio- 
logic advantages attributable to the ITA conduit. 
The apparent beneficial effects of ITA endothelium- 
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Fig. 6. Ex vivo bioassay of intraluminal release of endo- 
genous prostanoids in excised ITA conduits in ENDO (n 
= 3) and NoENDO (n = 2) groups. Conduit effluent from 
the ENDO group induced greater elaxation of normal 
coronary artery smooth muscle rings (relaxation expressed 
as a percentage of the maximal contraction achieved by 
prostaglandin Fa~ ) than did that from the NoENDO 
group (average 67% versus 23% relaxation). The in- 
creased smooth muscle relaxation induced by conduit 
effluent from the ENDO group was nearly eliminated by 
addition to conduit perfusate of indomethacin, a blocker 
of prostanoid synthesis. This indicates greater intralumi- 
nal release of endogenous prostacyclin or other endoge- 
nous vasoactive prostanoids by endothelialized conduits. 
derived prostacyclin on downstream myocellular 
function may in part account for the early postop- 
erative survival benefits attributed to use of an ITA 
conduit in patients undergoing coronary bypass 
grafting. 37 Also, additional long-term clinical bene- 
fits of ITA conduit s may be derived from the fact 
that elevated levels of endothelium-derived prosta- 
cyclin in ITA conduit efftuent may act to inhibit 
downstream platelet-mediated coronary v socon- 
striction and also to attenuate myocardial stunning 
resulting from subsequent episodes of transient 
myocardial ischemia. 
Recently, studies have indicated the feasibility of 
gene transfer to endothelial cells 38' 39 and of gene> 
ating segments of arterial vessels containing enet- 
ically modified cells. 4° These methods offer the 
possibility of favorably altering vessel wall biology to 
render native coronary vessels or coronary bypass 
conduits more resistant o thrombosis, my0intimal 
hyperplasia, and atherosclerotic degeneration. Our 
data suggest he possibility that populating autolo- 
gous or prosthetic bypass conduits with genetically 
modified endothelial cells with a high capacity for 
expression of specific polypeptides, uch as prosta- 
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cyclin, might also be beneficial and should be further 
investigated. 
Characteristics of bypass conduit vessel wall biol- 
ogy significantly influence downstream myocardial 
contractile function. The potential for engineering 
bypass conduits with genetically modified endothe- 
lial cells for optimal performance in the coronary 
circulation requires further study. ITA coronary 
bypass grafting in the conscious canine represents a 
uniquely suitable model for further investigation of 
endothelium-mediated myocardial events in the in- 
tact circulation. 
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